Akebia Therapeutics (AKBA) to Showcase Innovations at Kidney Conference
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company dedicated to improving the lives of those affected by kidney disease, has announced that Nik Grund, the Chief Commercial Officer, will participate in a Fireside Chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference. This event is scheduled for Monday, July 14, at 10:00 AM EDT.
For those interested in following the discussion, a webcast of the presentation will be available through the "Investors" section of Akebia's official website at https://ir.akebia.com following the conference.
About Akebia Therapeutics
Founded in 2007 and headquartered in Cambridge, Massachusetts, Akebia Therapeutics, Inc. is committed to advancing the treatment landscape for kidney disease. For additional insights and updates, please visit our website at www.akebia.com. Note that this website link is not part of this press release.
For further inquiries, please reach out to:
Mercedes Carrasco
Email: info@akebia.com
Stay updated with the latest news and developments by visiting Inside Ticker and following the performance of Akebia Therapeutics at insideticker.com/ticker/akba.